Selective inhibition of glycogen synthase kinase 3α corrects pathophysiology in a mouse model of fragile X syndrome

Copyright © 2020 The Authors, some rights reserved. Fragile X syndrome is caused by FMR1 gene silencing and loss of the encoded fragile X mental retardation protein (FMRP), which binds to mRNA and regulates translation. Studies in the Fmr1-/y mouse model of fragile X syndrome indicate that aberrant...

Full description

Bibliographic Details
Main Authors:	McCamphill, Patrick K. (Author), Stoppel, Laura J. (Author), Senter, Rebecca K. (Author), Lewis, Michael C. (Author), Heynen, Arnold J. (Author), Stoppel, David C. (Author), Sridhar, Vinay (Author), Collins, Katie A. (Author), Shi, Xi (Author), Pan, Jen Q. (Author), Madison, Jon (Author), Cottrell, Jeffrey R. (Author), Huber, Kimberly M. (Author), Scolnick, Edward M. (Author), Holson, Edward B. (Author), Wagner, Florence F. (Author), Bear, Mark F. (Author)
Format:	Article
Language:	English
Published:	American Association for the Advancement of Science (AAAS), 2022-03-14T18:03:06Z.
Subjects:	Article
Online Access:	Get fulltext

by McCamphill, Patrick K, Stoppel, Laura J, Senter, Rebecca K, Lewis, Michael C, Heynen, Arnold J, Stoppel, David C, Sridhar, Vinay, Collins, Katie A, Shi, Xi, Pan, Jen Q, Madison, Jon, Cottrell, Jeffrey R, Huber, Kimberly M, Scolnick, Edward M, Holson, Edward B, Wagner, Florence F, Bear, Mark F
Published 2021

Get fulltext

Article

Selective inhibition of glycogen synthase kinase 3α corrects pathophysiology in a mouse model of fragile X syndrome

Similar Items